Urinary Tract Infection Treatment Market Forecast
to 2026 with Key Companies Profile, Supply and
Growth Factors
Urinary Tract Infection (UTI) is caused when bacteria enters the urethra and infects the urinary
bladder, causing severe health issues. UTI infections are common health problems in females
than in males with biologic factors accounting as the major cause. Antibiotics are usually the
first line of treatment prescribed by doctors for urinary tract infections. According to the site of
manifestation by the microbe, infections are classified as cystitis (bladder), urethritis (urethra),
prostatitis (prostate) or pyelonephritis (kidney). Painful and increased frequency of urination,
excessive and involuntary passing of urine at night are the common symptoms associated with
UTI. Hospitalized patients using urinary catheters are at a higher risk for developing UTI.
Request PDF Brochure Of Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/1178
Increasing prevalence of recurring urinary infections is expected to boost growth of the urinary
tract infection treatment market
Rise in chronic kidney diseases and increasing use of urinary catheterization is leading to
development of urinary infections and this is expected to be major growth drivers for urinary
tract infection market. According to the Centers of Disease Control and Prevention, 2016,
UTIs are the most common bacterial infections globally, affecting 150 million people every year.
Furthermore, about 10 in 25 women and 3 in 25 men are estimated to have symptoms of at
least one UTI during their lifetime. According to the study by Sultan Qaboos University Medical
Journal, 2013, around 50–60% of women report at least one UTI in their lifetime, and one in
three will have at least one symptomatic UTI necessitating antibiotic treatment by age 24. Also,
patients with diabetes have a higher frequency of UTIs, due to the presence of long-term
complications of diabetes such as neuropathy. According to the American Diabetes Association,
in 2017, 9.4% of the people diagnosed with type 2 diabetes had a UTI compared to only 5.7%
of people without diabetes.